Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MediPharm Labs FY 2024 Revenue CAD 45.205M up from 36.819M YoY and EPS CAD (0.03) up from (0.04) YoY

Author: Benzinga Newsdesk | March 31, 2025 06:59am

MediPharm Labs (OTC:MEDIF) will report on Q4 2024.

Posted In: MEDIF